Lupin, Merck KGaA In Advanced Talks For Complex Generics Deal
This article was originally published in PharmAsia News
Executive Summary
Changing landscape of the global pharmaceutical market is likely bringing India’s Lupin and German’s Merck closer. Industry sources say a deal is close to being announced.